Spero Therapeutics Inc SPRO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/29/22 EDT
2.00quote price arrow up+0.03 (+1.52%)
Volume
32,560
Close
1.97quote price arrow down-0.08 (-3.90%)
Volume
1,968,747
52 week range
0.68 - 19.14
Loading...
  • Open1.96
  • Day High2.07
  • Day Low1.91
  • Prev Close1.97
  • 52 Week High19.14
  • 52 Week High Date09/29/21
  • 52 Week Low0.68
  • 52 Week Low Date08/02/22

Key Stats

  • Market Cap69.09M
  • Shares Out35.07M
  • 10 Day Average Volume29.93M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change-87.7

KEY STATS

  • Open1.96
  • Day High2.07
  • Day Low1.91
  • Prev Close1.97
  • 52 Week High19.14
  • 52 Week High Date09/29/21
  • 52 Week Low0.68
  • 52 Week Low Date08/02/22
  • Market Cap69.09M
  • Shares Out35.07M
  • 10 Day Average Volume29.93M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change-87.7

RATIOS/PROFITABILITY

  • EPS (TTM)-3.48
  • P/E (TTM)-0.57
  • Fwd P/E (NTM)-1.65
  • EBITDA (TTM)-93.642M
  • ROE (TTM)-179.55%
  • Revenue (TTM)9.87M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,147.64%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Spero Therapeutics Inc

 

Profile

MORE
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant (MDR) bacterial infections, and rare diseases where there is unmet medical and patient need. Its lead product candidate, tebipenem pivoxil hydrobromide (tebipenem HBr) is designed to be the first oral carbapenem-class antibiotic for use to treat certain bacterial...
Milind Deshpande Ph.D.
Independent Chairman of the Board
Ankit Mahadevia M.D.
President, Chief Executive Officer, Director
Satyavrat Shukla
Chief Financial Officer
Address
675 Massachusetts Ave Ste 14
Cambridge, MA
02139-3309
United States

Top Peers

SYMBOLLASTCHG%CHG
CRIS
Curis Inc
0.7377-0.0128-1.7055%
EYEN
Eyenovia Inc
1.98-0.08-3.88%
TCRX
TScan Therapeutics Inc
3.13+0.32+11.39%
ORTX
Orchard Therapeutics PLC
0.4768-0.0087-1.792%
HOOK
HOOKIPA Pharma Inc
1.46-0.04-2.67%